title: [Management of patients with EHEC/HUS. Lessons and perspectives from clinical infectious disease specialists].
abstract: The 2011 EHEC/HUS outbreak created uncertainty regarding the previous recommendations of withholding antibiotic therapy and regarding rational measures for prevention of invasive meningococcal disease after treatment with the monoclonal antibody eculizumab. For both these areas, an expert panel of the German Society for Infectious Diseases in cooperation with representatives of other learned societies and health institutions has drafted and consented guidelines that were published online on 1 June 2011 (i.e.,  ~10 days after the peak of the epidemic) and 4 June 2011. A summary of the guidelines in English was made available online on 4 June 2011. The time until ad hoc guidelines are made publicly available should and can be shortened in similar scenarios in the future. To this end-among other things-scientific societies in Germany linked  to infectious diseases and medical microbiology have established a permanent working group called AFIM. This working group will facilitate timely identification and appointment of experts and expert panels, and will make use of new ways of rapid and effective sharing and dissemination of knowledge and ad hoc guidelines in the medical community and public domain if needed. In the case of disease outbreaks, immediate telephone conferences among all professionals involved, close cooperation between institutions and expert groups, and avoidance of premature unconsented information and press releases will be critical. We expect that proceeding in this way will also have a major impact on proper planning, professional design, and adequate analysis of clinical studies and endpoints appropriate for the outbreak situation.
authors.affiliation: Zentrum Infektiologie und Reisemedizin und IFB-Zentrum für chronische Immundefizienz, Medizinische Universitätsklinik Freiburg, Hugstetterstr. 55, 79106, Freiburg, Deutschland. kern@if-freiburg.de
authors.forename: W V
authors.initials: WV
authors.lastname: Kern
mesh_terms: D004196:Disease Outbreaks / Q000517:prevention & control* / Q000706:statistics & numerical data*; D005858:Germany / Q000453:epidemiology; D058015:Health Communication / Q000592:standards*; D006463:Hemolytic-Uremic Syndrome / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control*; D006801:Humans; D020814:Meningitis, Escherichia coli; D017410:Practice Guidelines as Topic; D015995:Prevalence; D054323:Shiga-Toxigenic Escherichia coli